Hypertension Management Guidelines

Management of hypertension

Many guidelines exist for the management of hypertension. Most groups, including the JNC, the American Diabetes Associate (ADA), and the American Heart Association/American Stroke Association (AHA/ASA) recommend lifestyle modification as the first step in managing hypertension.

Lifestyle modifications

JNC 7 recommendations to lower BP and decrease cardiovascular disease risk include the following, with greater results achieved when 2 or more lifestyle modifications are combined:

  • Weight loss (range of approximate systolic BP reduction [SBP], 5-20 mm Hg per 10 kg)
  • Limit alcohol intake to no more than 1 oz (30 mL) of ethanol per day for men or 0.5 oz (15 mL) of ethanol per day for women and people of lighter weight (range of approximate SBP reduction, 2-4 mm Hg)
  • Reduce sodium intake to no more than 100 mmol/day (2.4 g sodium or 6 g sodium chloride; range of approximate SBP reduction, 2-8 mm Hg)
  • Maintain adequate intake of dietary potassium (approximately 90 mmol/day)
  • Maintain adequate intake of dietary calcium and magnesium for general health
  • Stop smoking and reduce intake of dietary saturated fat and cholesterol for overall cardiovascular health
  • Engage in aerobic exercise at least 30 minutes daily for most days (range of approximate SBP reduction, 4-9 mm Hg)

The AHA/ASA recommends a diet that is low in sodium, is high in potassium, and promotes the consumption of fruits, vegetables, and low-fat dairy products for reducing BP and lowering the risk of stroke. Other recommendations include increasing physical activity (30 minutes or more of moderate-intensity activity on a daily basis) and losing weight (for overweight and obese persons).

Treatment Recommendations

The following are drug class recommendations for compelling indications based on various clinical trials:

  • Heart failure: Diuretic, beta-blocker, ACE inhibitor/ARB, aldosterone antagonist
  • Following myocardial infarction: Beta-blocker, ACE inhibitor
  • Diabetes:  ACE inhibitor/ARB
  • Chronic kidney disease: ACE inhibitor/ARB

 

American Society of Hypertension/International Society of Hypertension

Joint guidelines were issued by the American Society of Hypertension and the International Society of Hypertension (ASH/ISH)

 

Major Medical Condition

First-line Drugs

Added 2nd Drug


Added 3rd Drug

Diabetes (white and other non-African ancestry)

ARB or ACEI

CCB or thiazide diuretic


Alternative 2nd drug (CCB or thiazide diuretic)

Chronic kidney disease

ARB or ACEI

CCB or thiazide diuretic


Alternative 2nd drug (CCB or thiazide diuretic)

Coronary artery disease

Beta-blocker plus ARB or ACEI

CCB or thiazide diuretic


Alternative 2nd drug (CCB or thiazide diuretic)

Stroke

ACEI or ARB

CCB or thiazide diuretic


Alternative 2nd drug (CCB or thiazide diuretic)

Symptomatic heart failure

Beta-blocker plus ARB or ACEI plus diuretic plus spironolactone regardless of BP; CCB can be added if needed for BP control


ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin receptor blocker; BP = blood pressure; CCB = calcium channel blocker.

 

Doctors Liked to Read More

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71:e127-e248. 

https://emedicine.medscape.com/article/241381-guidelines 

https://www.guidelines.co.uk/cardiovascular/nice-hypertension-guideline/454934.article 

https://www.nice.org.uk/guidance/ng136 

 

Note: For informational purposes only. Consult your textbook for advising your patients.

This is for informational purposes only. You should consult your clinical textbook for advising your patients.